Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:141-147, 2006
DOI: 10.2337/diabetes.55.01.06.db05-1077
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spranger, J.
Right arrow Articles by Banks, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spranger, J.
Right arrow Articles by Banks, W. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Obesity Study

Adiponectin Does Not Cross the Blood-Brain Barrier but Modifies Cytokine Expression of Brain Endothelial Cells

Joachim Spranger1,2, Sulekha Verma3,4, Isabel Göhring1,2, Thomas Bobbert1,2, Joseph Seifert5, Amy L. Sindler6, Andreas Pfeiffer1,2, Stanley M. Hileman6, Matthias Tschöp7, and William A. Banks3,4

1 Department of Clinical Nutrition, German Institute of Human Nutrition, Potsdam, Germany
2 Department of Endocrinology, Diabetes and Nutrition, Charité-Universitymedicine Berlin, Berlin, Germany
3 Geriatric Research Educational Clincal Center, Veterans Affairs Medical Center, St. Louis, Missouri
4 Division of Geriatrics, Department of Internal Medicine, Saint Louis University School of Medicine, St. Louis, Missouri
5 Department of Neurology, Charité-Universitymedicine Berlin, Berlin, Germany
6 Department of Physiology and Pharmacology, West Virginia University, Morgantown, West Virginia
7 Department of Psychiatry, Obesity Research Center, University of Cincinnati, Genome Research Institute, Cincinati, Ohio

Address correspondence and reprint requests to Joachim Spranger, MD, Dept. of Clinical Nutrition, German Institute of Human Nutrition Potsdam, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany. E-mail: spranger{at}mail.dife.de or joachim.spranger{at}charite.de

Abbreviations: AMPK, cAMP kinase; BBB, blood-brain barrier; CNS, central nervous system; CSF, cerebrospinal fluid; IL, interleukin

Adiponectin has recently been reported to generate a negative energy balance by increasing energy expenditure. However, it is unclear whether such effects require the presence and direct action of the adiponectin protein in the central nervous system. In this study, neither radiolabeled nonglycosylated nor glycosylated globular adiponectin crossed the blood-brain barrier (BBB) in mice. In addition, adiponectin was not detectable in human cerebrospinal fluid using various established methods. Using murine cerebral microvessels, we demonstrated expression of adiponectin receptors, which are upregulated during fasting, in brain endothelium. Interestingly, treatment with adiponectin reduced secretion of the centrally active interleukin-6 from brain endothelial cells, a phenomenon that was paralleled by a similar trend of other proinflammatory cytokines. In summary, our data suggest that direct effects of endogenous adiponectin on central nervous system pathways are unlikely to exist. However, the identification of adiponectin receptors on brain endothelial cells and the finding of a modified secretion pattern of centrally active substances from BBB cells provides an alternate explanation as to how adiponectin may evoke effects on energy metabolism.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
T. D. Hoyda, M. Fry, R. S. Ahima, and A. V. Ferguson
Adiponectin selectively inhibits oxytocin neurons of the paraventricular nucleus of the hypothalamus
J. Physiol., December 15, 2007; 585(3): 805 - 816.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Neumeier, J. Weigert, R. Buettner, J. Wanninger, A. Schaffler, A. M. Muller, S. Killian, S. Sauerbruch, F. Schlachetzki, A. Steinbrecher, et al.
Detection of adiponectin in cerebrospinal fluid in humans
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E965 - E969.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
W. A. Banks, L. M. Willoughby, D. R. Thomas, and J. E. Morley
Insulin Resistance Syndrome in the Elderly: Assessment of functional, biochemical, metabolic, and inflammatory status
Diabetes Care, September 1, 2007; 30(9): 2369 - 2373.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. Ebinuma, T. Miida, T. Yamauchi, Y. Hada, K. Hara, N. Kubota, and T. Kadowaki
Improved ELISA for Selective Measurement of Adiponectin Multimers and Identification of Adiponectin in Human Cerebrospinal Fluid
Clin. Chem., August 1, 2007; 53(8): 1541 - 1544.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. Tanida, J. Shen, Y. Horii, M. Matsuda, S. Kihara, T. Funahashi, I. Shimomura, H. Sawai, Y. Fukuda, Y. Matsuzawa, et al.
Effects of Adiponectin on the Renal Sympathetic Nerve Activity and Blood Pressure in Rats
Experimental Biology and Medicine, March 1, 2007; 232(3): 390 - 397.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Bjursell, A. Ahnmark, M. Bohlooly-Y, L. William-Olsson, M. Rhedin, X.-R. Peng, K. Ploj, A.-K. Gerdin, G. Arnerup, A. Elmgren, et al.
Opposing Effects of Adiponectin Receptors 1 and 2 on Energy Metabolism
Diabetes, March 1, 2007; 56(3): 583 - 593.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Kos, A. L. Harte, N. F. da Silva, A. Tonchev, G. Chaldakov, S. James, D. R. Snead, B. Hoggart, J. P. O'Hare, P. G. McTernan, et al.
Adiponectin and Resistin in Human Cerebrospinal Fluid and Expression of Adiponectin Receptors in the Human Hypothalamus
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1129 - 1136.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. Fry, T. D. Hoyda, and A. V. Ferguson
Making Sense of It: Roles of the Sensory Circumventricular Organs in Feeding and Regulation of Energy Homeostasis
Experimental Biology and Medicine, January 1, 2007; 232(1): 14 - 26.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Rodriguez-Pacheco, A. J. Martinez-Fuentes, S. Tovar, L. Pinilla, M. Tena-Sempere, C. Dieguez, J. P. Castano, and M. M. Malagon
Regulation of Pituitary Cell Function by Adiponectin
Endocrinology, January 1, 2007; 148(1): 401 - 410.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. S. Ahima, Y. Qi, N. S. Singhal, M. B. Jackson, and P. E. Scherer
Brain Adipocytokine Action and Metabolic Regulation
Diabetes, December 1, 2006; 55(Supplement_2): S145 - S154.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Fry, P. M. Smith, T. D. Hoyda, M. Duncan, R. S. Ahima, K. A. Sharkey, and A. V. Ferguson
Area postrema neurons are modulated by the adipocyte hormone adiponectin.
J. Neurosci., September 20, 2006; 26(38): 9695 - 9702.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.